Latest Listings And Ipos News

AFT Pharmaceuticals reported a 6% increase in revenue to NZ$208 million for the year ending March 2025, but net profit fell 23%, prompting a modest final dividend declaration.

New World Resources Limited has entered a binding agreement for acquisition by Central Asia Metals Plc at a significant premium, valuing the company at approximately A$185 million. The transaction, unanimously recommended by New World’s board, is set to complete by September 2025, subject to shareholder and court approvals.

Aurora Energy Metals has received a further US$550,000 from Eagle Energy Metals, extending the option to acquire the Aurora Uranium Project and underpinning key development milestones.

Mayne Pharma has firmly rejected Cosette Pharmaceuticals’ assertion of a Material Adverse Change that could derail their acquisition scheme, insisting the deal process continues as planned.

Infomedia Ltd has responded to an ASX price query following a sharp share price decline and increased trading volume, denying any undisclosed material information. The company pointed to the recent closure of Celeste Funds, a known shareholder, as a potential external factor influencing market activity.

Island Pharmaceuticals has raised $3.6 million through a strategic share placement to advance its lead antiviral drug ISLA-101’s clinical development and broaden its asset portfolio ahead of pivotal Phase 2a/b trial results.

First Au Limited has entered a binding term sheet to progressively acquire full ownership of the Nimba Gold Project in Liberia, backed by a planned A$1 million equity raise to fund exploration. The project’s proximity to a major West African gold mine and promising drill results position FAU for a strategic expansion into a stable, mining-friendly jurisdiction.

Top End Energy has appointed New York-based Amvest Capital to spearhead its U.S. investor engagement and plans an American Depositary Receipt listing by Q3 2025, aiming to open doors to one of the world’s largest energy capital markets.

Webjet Group Limited reports resilient FY25 results following its recent demerger, with a strategic plan to double transaction value by FY30. Despite macroeconomic headwinds, the company maintains strong cash reserves and outlines ambitious growth initiatives.

Renergen Limited is poised to be acquired by US-based ASP Isotopes Inc. in a deal that aims to create a powerhouse in critical helium and isotope supply chains. The merger promises expanded market access and strategic value across key industries.

ASPI Isotopes Inc. has agreed to acquire Renergen Limited in an all-share deal, creating a vertically integrated global entity focused on critical materials for semiconductors, medical isotopes, and green energy. The transaction addresses Renergen’s liquidity challenges and positions the combined company for growth across multiple strategic sectors.

Janus Electric Holdings Limited will have its trading suspension lifted and resume quotation on the ASX from 21 May 2025 after meeting key listing requirements.